Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Senseonics Holdings Inc SENS

Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The... see more

Recent & Breaking News (NYSEAM:SENS)

Senseonics Launches New Remote Monitoring App for Android Users in US

Business Wire May 26, 2020

Local Coverage Determination Proposed for Implantable Continuous Glucose Monitors by Medicare Administrative Contractors

Business Wire May 14, 2020

Senseonics Announces Positive Coverage Decision for Eversense CGM from Several Blue Cross Blue Shield Plans

Business Wire May 6, 2020

Senseonics Eversense® Sensor Receives MRI Conditional Approval in Europe

Business Wire April 28, 2020

Senseonics Enters into New Credit Facilities with Certain Funds Managed by Highbridge Capital Management, LLC

Business Wire April 22, 2020

Senseonics Announces Equity Grants To Employees Under Inducement Plan

Business Wire April 3, 2020

Senseonics Exploring Strategic Options to Enhance Stakeholder Value

Business Wire March 23, 2020

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results

Business Wire March 12, 2020

Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for March 12, 2020 at 4:30 p.m. Eastern Time

Business Wire March 4, 2020

Senseonics Announces the FDA Approval to Continue the PROMISE Sensor Clinical Study in an Extended Cohort to 365 Days to Gather Feasibility Data

Business Wire February 26, 2020

Senseonics Reports at ATTD Glycemic Outcomes Across Adult Age Ranges with Real-World Eversense CGM Use

Business Wire February 24, 2020

Senseonics Announces a Positive Coverage Decision for Eversense CGM from Cigna

Business Wire February 18, 2020

Senseonics Announces Partnership with Companion Medical

Business Wire February 11, 2020

Senseonics Announces Equity Grants to Employees Under Inducement Plan

Business Wire January 3, 2020

Senseonics Launches Eversense CGM System with Non-Adjunctive Claim in the U.S.

Business Wire December 2, 2019

Senseonics Publishes Positive Longitudinal Performance Over Multiple Sensor Insertions and Removal Cycles of the Eversense® CGM System

Business Wire November 21, 2019

Senseonics Holdings, Inc. Reports Third Quarter 2019 Financial Results

Business Wire November 12, 2019

Medicare Establishes National Payment Rate for Eversense® CGM System

Business Wire November 12, 2019

Senseonics Holdings, Inc. Schedules Third Quarter 2019 Earnings Release and Conference Call for November 12, 2019 at 4:30 p.m. Eastern Time

Business Wire October 29, 2019

Senseonics Announces a Positive Coverage Decision for Eversense CGM From Humana

Business Wire October 24, 2019